Norgine Ventures completes £4 million financing with Collagen Solutions

London. 14th February 2017, 07.00 AM GMT. Norgine Ventures announced that it has provided financing of up to £4 million to Collagen Solutions plc. This investment recognises the high quality of the collagen products of Collagen Solutions, the opportunity to continue the growth trajectory through commercial expansion and the potential of their pipeline of proprietary […]

Continue reading

Norgine Ventures completes €3 Million Financing With PulseCath

London. 10 October 2016, 09.00 AM BST. Norgine Ventures announced that it has provided financing of up to €3 million to PulseCath B.V.. This investment recognises the unique positioning of PulseCath’s cardiac assist devices and the growth potential of the company. PulseCath, based in the Netherlands, develops and commercialises innovative left ventricle assist devices. The […]

Continue reading

Norgine Ventures completes €5 million Financing with Q3 Medical Devices

London, England, June 21, 2016 – Q3 Medical Devices today announced that it has received financing of up to €5million from Norgine Ventures. This investment recognises the growth prospects of Q3 Medical Devices, an Irish based holding company with multiple operations in Germany focused on the development, manufacturing and distribution of minimally invasive devices for […]

Continue reading

Norgine Ventures Announces Successful Conclusion of its Investment in Stanmore Implants

London. 17 May 2016, 07:00 am BST. Norgine Ventures announced that it has successfully exited its investment in Stanmore Implants Worldwide Limited (SIW) following the acquisition of SIW by Stryker Corporation (“Stryker”) in an all cash transaction for £35.6m. Stanmore Implants is an orthopaedics company focused on the specialist design and manufacture of patient-specific implants […]

Continue reading

Norgine Ventures Announces Successful Conclusion of its Investment in Innovative Pharma Company Internis

London. 12 January 2015, 09.00 AM GMT.  Norgine Ventures today announced that it has successfully exited its investment in Internis Pharmaceuticals Limited following the acquisition of Internis by an undisclosed pharmaceutical company in December 2014. This transaction represents a significant achievement for this exciting and innovative British company. Internis, founded in 2010 by Charles Tannenbaum, […]

Continue reading

Norgine Ventures completes €4 million financing with SpineVision SA

London. 3 November 2014, 07:00 AM BST. Norgine Ventures today announced that it has provided financing of €4 million to SpineVision SA. The financing was realised in form of private bonds with warrants. Norgine Ventures is a business entity of Norgine, a European specialist pharmaceutical company. Norgine Ventures’ investment will help SpineVision finance development of […]

Continue reading